menu
Presently, over 65 companies claim to offer drug repurposing-related services to the global pharmaceutical industry
Presently, over 65 companies claim to offer drug repurposing-related services to the global pharmaceutical industry
Presently, over 65 companies claim to offer drug repurposing-related services to the global pharmaceutical industry

Presently, over 65 companies claim to offer drug repurposing-related services to the global pharmaceutical industry

Repurposing of marketed / shelved / pipeline candidates forthe treatment of diseases (different from original target indications) hasemerged as a viable business strategy. The rising popularity of this approachcan further be attributed to various benefits, such as reduced developmenttimelines, decreased investments and relatively higher success rates(considering that the safety profiles of such candidates have already beenestablished).

 

To order this 250+ page report, which features 100+ figuresand 140+ tables, please visit this link

 

The USD 1.2 billion (by 2030) financial opportunity withinthe drug repurposing service providers market has been analyzed across thefollowing segments:

§  Typeof Repurposing Approaches

§  Disease-centricapproach

§  Target-centricapproach

§  Drug-centricapproach

§  TherapeuticArea

§  SameTherapeutic Area

§  DifferentTherapeutic Area

§  Typeof Drug Molecule

§  Biologics 

§  SmallMolecule

§  KeyGeographical Region 

§  NorthAmerica

§  Europe

§  Asia-Pacific

 

The Drug Repurposing Service Providers Market, 2020-2030 report features thefollowing companies, which we identified to be key players in this domain:

§  Auxillis Pharma

§  ChemBio Discovery Solutions

§  Excelra

§  GVK Bio

§  Iris Pharma

§  Lantern Pharma

§  PanXome

§  Pharmacelera

§  Physiogenex

§  Smart Pharma

§  Socium

§  SOM Biotech

 

Table of Contents

 

1. Preface

2. Executive Summary


3. Introduction

4. Market Landscape

5. Role of Non-Profit / Academic Organizations

 

6. Company Profiles

7.  Partnerships

8. Big Pharma Initiatives

9. Case Study: Discontinued Drug Development Programs

10. Cost Saving Analysis

11. Market Forecast and Opportunity Analysis

12.  Covid-19 Impact onDrug Repurposing Service Providers Market

13. Recent Advancements and Trends in Outsourcing of DrugRepurposing

 

14. Interview Transcripts

 

15. Appendix 1: List of Potential Drug-Indication Candidates forDrug Repurposing

 

16. Appendix 2: Tabulated Data

 

17. Appendix 3: List of Companies and Organizations

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com